ROCKVILLE, Md., Sept. 8, 2008 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF) today announced that it has successfully completed a $1.5 million capital raise through the issuance of two million shares at a purchase price of $0.75 per share and associated one million four-year warrants exercisable at $1.00. The funds were raised in a registered direct offering under the Company's existing shelf registration. Cytomedix management and members of the Board of Directors participated in the raise on terms and conditions identical to those offered to other investors, investing an aggregate $100,000. The offering closed on September 5, 2008. The Company plans to use the proceeds for general working capital purposes.
